Cart
sales@molnova.com
Benzydamine
CAS No. 642-72-8
Benzydamine( —— )
Catalog No. M22988 CAS No. 642-72-8
Benzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 50MG | 110 | In Stock |
|
| 100MG | 166 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzydamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
-
DescriptionBenzydamine is a benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. Benzydamine is used to reduce post-surgical and post-traumatic pain and edema and to promote healing.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number642-72-8
-
Formula Weight309.4
-
Molecular FormulaC19H23N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.N P Singh, J K Makkar, V Wourms, P M Singh.Topical benzydamine for preventing postoperative sore throat.Anaesthesia. 2018 Oct;73(10):1297.
molnova catalog
related products
-
Sulbutiamine
Sulbutiamine is an antioxidant that act by inhibiting oxidative stress induced retinal ganglion cell death.
-
ShK-Dap22
Extremely potent KV1.3 channel blocker (Kd = 23 pM for mKV1.3 currents). Selective for KV1.3 over other mammalian potassium channels (IC50 values are 23, 1800, 10500, 37000 and 39000 pM for mKV1.3, mKV1.1, hKV1.6, mKV1.4 and rKV1.2 respectively, and >100000 pM for hKV1.5, mKV1.7, hKV3.1, rKV3.4 and hKCa4). Suppresses T cell activation in vitro (IC50 < 500 pM).
-
Divarasib
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM.
